Short Term Trading Week Starting: 19 August, page-13

STTCOMP TLX FA LONG

Telix Pharmaceutical - an oncology company focussing on renal, prostate and brain (GBM) cancers.
SP - $1.34
MC - around $248m

Just completing a capital raising at $1.30. Professional placement was completed late last month. SPP has closed and shares will be allocated later this week (22 Aug). I like that the SP is approaching the placement price, creating an opportunity to buy at the same level as professionals. It's a pretty impressive company with both diagnostic and therapeutic potential and a pretty steady news flow and upcoming milestones. For more info, you can refer to the investor presentation released on July 17 or you can refer to an earlier tip by @Michaeljob. He's more articulate than me! Might be a bit early with this tip but there should be a good entry opportunity this week for anyone interested in the stock.